Are Wesfarmers or Sigma shares a better buy in the pharmacy arena?

These two stocks are both leaders in the industry.

| More on:
Female pharmacist smiles with a digital tablet.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Both Wesfarmers Ltd (ASX: WES) shares and Sigma Healthcare Ltd (ASX: SIG) shares offer investors exposure to the pharmacy sector.

Wesfarmers may be best known for its divisions like Bunnings, Kmart, and Officeworks, but it also owns Australian Pharmaceutical Industries (API).

API owns several brands, including Priceline, Soul Pattinson Chemist, Pharmacist Advice, SILK Laser, and Clear Skincare. Soul Pattinson Chemist and Pharmacist Advice are operated by independent pharmacies, while over 400 Priceline Pharmacy locations are franchise stores.

Sigma Healthcare currently provides wholesale and distribution services to pharmacies. It also owns retail pharmacy brands Amcal and Discount Drug Stores, as well as an independent offering called PriceSave.

What's the appeal of Wesfarmers shares with healthcare?

Wesfarmers only entered the healthcare space in the last few years, acquiring the previously-listed Australian Pharmaceutical Industries. The company believed it could bring its scale and expertise to the pharmacy sector.

In the FY24 result, the Wesfarmers health division delivered a solid result, with 5.9% revenue growth to $5.6 billion, 7.3% operating profit (EBITDA) growth to $133 million, 10% earnings before interest and tax (EBIT) growth to $55 million and 11.1% earnings before tax (EBT) growth to $50 million.

Priceline delivered strong sales growth thanks to store network expansion, promotional activity and online sales growth. In the second half of FY24, it reduced prices on a range of commonly purchased products. The pharmaceutical wholesale division delivered "positive sales growth" through net customer wins and improved service levels.

Wesfarmers said its digital health had a pleasing year after acquiring InstantScripts, which delivered "strong revenue growth".

Wesfarmers says it's well-positioned to deliver improved financial performance and grow sales while investing in its businesses to accelerate growth and improve returns. It aims to capitalise on long-term sector tailwinds.

It's looking to expand the franchise Priceline store network, improve its digital and e-commerce offerings, improve the wholesale proposition and optimise its supply chain.

Why are Sigma Healthcare shares appealing?

The key reason the market is very excited about Sigma is its impending merger with Chemist Warehouse, now approved by the ACCC, to create a strong player in the space.

Sigma's recent FY25 half-year result was solid, with 17% net revenue growth to $1.84 billion and 20.6% growth of EBIT to $18 million. It's clear the Wesfarmers' healthcare division is larger than Sigma.

However, Sigma Healthcare will become a much more profitable business once combined with Chemist Warehouse, which recently reported its own FY24 result, which showed $3.3 billion in revenue and, most importantly, $540 million in net profit.

The combination of the two businesses is expected to unlock "significant efficiencies", with cost synergies estimated at an initial $60 million per annum.

Not only is Chemist Warehouse already very profitable, but it's also expanding its store network internationally in places like China, New Zealand, and Ireland. It also recently launched Optometrist Warehouse, giving it another growth runway in Australia.

My choice for pharmacy exposure

I think Sigma Healthcare shares are the clear winner, with the compelling merger benefits that could come. Plus, Chemist Warehouse has an appealing growth runway that isn't just Australian-based.

API has a commendable outlook, but it only contributed $50 million to Wesfarmers' earnings in FY24. Bunnings made $2.25 billion, and Kmart Group made $958 million. In other words, API is a very small piece of Wesfarmers' profit and not integral to Wesfarmers shares.

It will be many months before Sigma's merger is finalised with Chemist Warehouse, but the outlook is compelling.

Should you invest $1,000 in Sigma Healthcare right now?

Before you buy Sigma Healthcare shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Sigma Healthcare wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 7 February 2025

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Wesfarmers. The Motley Fool Australia has positions in and has recommended Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Two lab workers fist pump each other.
Healthcare Shares

3 reasons to buy CSL shares today

Two investment experts expect a big turnaround for CSL shares in 2025.

Read more »

Business people discussing project on digital tablet.
Healthcare Shares

Down 4%, is the ResMed share price in the buy zone?

Do analysts think investors should be buying the dip? Let's see what they are saying.

Read more »

A man holds his head in his hands, despairing at the bad result he's reading on his computer.
Healthcare Shares

Guess which ASX 100 share is sinking 8% because of Trump's tariffs

Donald Trump has dealt this company a big blow. What's happening?

Read more »

Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
Healthcare Shares

Up 1,090% in a year, why is the Mesoblast share price leaping higher again on Friday?

Mesoblast shares have surged more than 1,000% over the last 12 months.

Read more »

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Earnings Results

ResMed shares rise on strong Q2 result

Let's see how this sleep treatment company performed during the second quarter.

Read more »

Person holding Australian dollar notes, symbolising dividends.
Healthcare Shares

$1,000 invested in Mesoblast shares at the start of 2024 is now worth…

Did this biotech company deliver the goods for investors? Let's see what a $1,000 investment would be worth.

Read more »

A company manager presents the ASX company earnings report to shareholders at an AGM.
Healthcare Shares

Sigma share price drops after shareholders vote on Chemist Warehouse merger

The results are in.

Read more »

Man with his hand out the front, symbolising a trading halt.
Healthcare Shares

Halted: What's going on with Sigma shares today?

Sigma investors would be holding their breath right now.

Read more »